Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38

W G Junger, D B Hoyt, R E Davis, C Herdon-Remelius, S Namiki, H Junger, W Loomis, A Altman, W G Junger, D B Hoyt, R E Davis, C Herdon-Remelius, S Namiki, H Junger, W Loomis, A Altman

Abstract

Excessive neutrophil activation causes posttraumatic complications, which may be reduced with hypertonic saline (HS) resuscitation. We tested if this is because of modulated neutrophil function by HS. Clinically relevant hypertonicity (10-25 mM) suppressed degranulation and superoxide formation in response to fMLP and blocked the activation of the mitogen activated protein kinases (MAPK) ERK1/2 and p38, but did not affect Ca2+ mobilization. HS did not suppress oxidative burst in response to phorbol myristate acetate (PMA). This indicates that HS suppresses neutrophil function by intercepting signal pathways upstream of or apart from PKC. HS activated p38 by itself and enhanced degranulation in response to PKC activation. This enhancement was reduced by inhibition of p38 with SB203580, suggesting that p38 up-regulation participates in HS-induced enhancements of degranulation. HS had similar effects on the degranulation of cells that were previously stimulated with fMLP, but had no effect on its own, suggesting that HS enhancement of degranulation requires another signal. We conclude that depending on other stimuli, HS can suppress neutrophil activation by intercepting multiple receptor signals or augment degranulation by enhancing p38 signaling. In patients HS resuscitation may reduce posttraumatic complications by preventing neutrophil activation via chemotactic factors released during reperfusion.

References

    1. Shock. 1994 Jul;2(1):23-8
    1. J Biol Chem. 1995 Mar 31;270(13):7420-6
    1. Blood. 1995 Sep 1;86(5):1649-60
    1. J Trauma. 1995 Sep;39(3):411-7
    1. J Biol Chem. 1997 Jan 10;272(2):937-44
    1. J Clin Invest. 1997 Mar 1;99(5):975-86
    1. Biochem Biophys Res Commun. 1997 Mar 17;232(2):474-7
    1. J Trauma. 1997 Mar;42(3):437-43; discussion 443-5
    1. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3052-7
    1. J Cell Physiol. 1997 Jul;172(1):94-108
    1. Fed Proc. 1966 Jul-Aug;25(4):1375-9
    1. J Appl Physiol. 1972 Feb;32(2):182-4
    1. Am J Physiol. 1980 Nov;239(5):H664-73
    1. J Immunol Methods. 1983 Oct 28;63(3):347-57
    1. J Trauma. 1987 Jan;27(1):32-9
    1. N Engl J Med. 1989 Feb 9;320(6):365-76
    1. J Trauma. 1990 Jun;30(6):646-50; discussion 650-1
    1. Artif Organs. 1990 Dec;14(6):410-2
    1. Ann Surg. 1991 May;213(5):482-91
    1. South Med J. 1991 Jun;84(6):692-6
    1. Age Ageing. 1992 Jan;21(1):56-60
    1. J Urol. 1993 Feb;149(2):386-9
    1. J Immunol Methods. 1993 Mar 15;160(1):73-9
    1. Science. 1993 Mar 19;259(5102):1760-3
    1. Life Sci. 1993;52(18):1481-6
    1. J Trauma. 1993 May;34(5):622-32; discussion 632-3
    1. Arch Surg. 1993 Sep;128(9):1003-11; discussion 1011-3
    1. Science. 1993 Oct 22;262(5133):566-9
    1. J Infect Dis. 1994 Apr;169(4):839-46
    1. Nature. 1994 May 19;369(6477):242-5
    1. J Clin Invest. 1994 Aug;94(2):815-23
    1. Science. 1994 Aug 5;265(5173):806-8
    1. Science. 1994 Aug 5;265(5173):808-11
    1. J Urol. 1994 Nov;152(5 Pt 1):1622-5
    1. Science. 1995 Jul 28;269(5223):554-8

Source: PubMed

3
订阅